PH12013501809A1 - Endoparasite control agent - Google Patents

Endoparasite control agent

Info

Publication number
PH12013501809A1
PH12013501809A1 PH1/2013/501809A PH12013501809A PH12013501809A1 PH 12013501809 A1 PH12013501809 A1 PH 12013501809A1 PH 12013501809 A PH12013501809 A PH 12013501809A PH 12013501809 A1 PH12013501809 A1 PH 12013501809A1
Authority
PH
Philippines
Prior art keywords
control agent
endoparasite control
endoparasite
orally
salt
Prior art date
Application number
PH1/2013/501809A
Inventor
Kiyoshi Kita
Akiyuki Suwa
Original Assignee
Nihon Nohyaku Co Ltd
Univ Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd, Univ Tokyo filed Critical Nihon Nohyaku Co Ltd
Publication of PH12013501809A1 publication Critical patent/PH12013501809A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Provided are an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): or a salt thereof as an active ingredient, and a method for controlling endoparasites, comprising orally or parenterally administering the endoparasite control agent.
PH1/2013/501809A 2011-03-02 2012-03-01 Endoparasite control agent PH12013501809A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011045042 2011-03-02
PCT/JP2012/055190 WO2012118139A1 (en) 2011-03-02 2012-03-01 Internal parasiticide

Publications (1)

Publication Number Publication Date
PH12013501809A1 true PH12013501809A1 (en) 2013-10-14

Family

ID=46758065

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/501809A PH12013501809A1 (en) 2011-03-02 2012-03-01 Endoparasite control agent

Country Status (16)

Country Link
US (1) US9447042B2 (en)
EP (1) EP2682115B1 (en)
JP (1) JP5973989B2 (en)
KR (1) KR101856577B1 (en)
CN (2) CN103415288B (en)
AU (1) AU2012224015B2 (en)
BR (1) BR112013021337B1 (en)
CA (1) CA2828060C (en)
CL (1) CL2013002507A1 (en)
ES (1) ES2625990T3 (en)
MX (1) MX345339B (en)
PH (1) PH12013501809A1 (en)
RU (1) RU2596788C2 (en)
UA (1) UA114287C2 (en)
WO (1) WO2012118139A1 (en)
ZA (1) ZA201305979B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010014077A (en) 2008-06-26 2011-04-05 Kanemaru Shinichi Agent for regenerating tympanic membrane or external auditory canal.
US20140256728A1 (en) 2011-11-02 2014-09-11 Bayer Intellectual Property Gmbh Compounds with nematicidal activity
US9301526B2 (en) 2011-11-02 2016-04-05 Bayer Intellectual Property Gmbh Compounds with nematicidal activity
WO2013064521A1 (en) * 2011-11-04 2013-05-10 Syngenta Participations Ag Pesticidal compounds
HRP20192191T1 (en) * 2011-11-25 2020-02-21 Bayer Intellectual Property Gmbh USE OF ARYL AND HETARYL CARBOXAMIDE AS ENDOPARASITICIDES
EP2782572A1 (en) * 2011-11-25 2014-10-01 Bayer Intellectual Property GmbH Use of fluopyram for controlling endoparasites
ES2932624T3 (en) * 2012-08-30 2023-01-23 Univ Tokyo Endoparasite Control Agent
BR112015000126A2 (en) 2012-08-30 2019-10-01 Nihon Nohyaku Co Ltd An internal parasitism insect control agent and directions for use for the same
TWI598325B (en) * 2012-10-12 2017-09-11 Ｈ 朗德貝克公司 Benzoamide
TW201427947A (en) 2012-10-12 2014-07-16 Lundbeck & Co As H Cyclic amines
EP2730570A1 (en) * 2012-11-13 2014-05-14 Bayer CropScience AG Pyridyloxyal alkyl carboxamides and their use as endoparasiticides and nematicide
TW201507722A (en) * 2013-04-30 2015-03-01 Bayer Cropscience Ag N-(2-halogen-2-phenethyl)carboxamides as nematicides and endoparasiticides
AR097423A1 (en) 2013-08-26 2016-03-16 Bayer Cropscience Ag COMPOUNDS WITH PESTICIATED ACTIVITY
UY35772A (en) * 2013-10-14 2015-05-29 Bayer Cropscience Ag NEW PESTICIDED COMPOUNDS
AR098475A1 (en) * 2013-11-26 2016-06-01 Bayer Cropscience Ag PESTICIDE COMPOUNDS AND USES
JPWO2015125824A1 (en) 2014-02-18 2017-03-30 日産化学工業株式会社 Alkynylpyridine substituted amide compounds and pest control agents
US20160367532A1 (en) * 2014-03-05 2016-12-22 The University Of Tokyo Endoparasite control agent
CN106061484B (en) * 2014-03-05 2020-01-24 国立大学法人东京大学 Internal parasite control agent
UY36196A (en) * 2014-07-25 2016-02-29 Bayer Animal Health Gmbh COMPOUNDS TO USE IN ANTIHELMINTIC TREATMENT
TW201629009A (en) 2014-10-28 2016-08-16 拜耳動物保健有限公司 Compounds for use in anthelminthic treatment
WO2016066636A1 (en) * 2014-10-29 2016-05-06 Bayer Cropscience Aktiengesellschaft N-(2-halogen-2-phenethyl)carboxamides as fungicides
ES2747794T3 (en) 2014-12-02 2020-03-11 Bayer Cropscience Ag Bicyclic compounds like pesticides
WO2018132582A1 (en) 2017-01-12 2018-07-19 Carnegie Mellon University Surfactant assisted formation of a catalyst complex for emulsion atom transfer radical polymerization processes
RU2673677C1 (en) * 2017-10-17 2018-11-29 ФАНО России, Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений им. К.И. Скрябина (ФГБНУ "ВНИИП им. К.И. Скрябина") Agent for disinvasion against buxtonella sulcata in cattle
USD888149S1 (en) 2018-01-04 2020-06-23 Samsung Electronics Co., Ltd. Type font
US11472894B2 (en) 2018-07-23 2022-10-18 Carnegie Mellon University Enzyme-assisted ATRP procedures
WO2020028715A1 (en) 2018-08-01 2020-02-06 Russell Alan J Amino-reactive positively charged atrp initiators that maintain their positive charge during synthesis of biomacro-initiators
WO2022128746A1 (en) * 2020-12-14 2022-06-23 Elanco Tiergesundheit Ag Quinoline derivatives as endoparasiticides

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539739A (en) 1976-07-12 1978-01-28 Nippon Nohyaku Co Ltd #-trifluoromethyl-##-isoproxybenzoic acid anilide, its preparation and its use
US4093743A (en) 1976-07-12 1978-06-06 Nihon Nohyaku Co., Ltd. Novel benzoic anilide derivative and fungicide containing same
IL88133A0 (en) 1987-10-26 1989-06-30 Lilly Co Eli N-phenylalkylbenzamide fungicides
DE4400464A1 (en) * 1994-01-11 1995-07-13 Bayer Ag Endoparasiticidal agents
GB9601128D0 (en) * 1995-08-11 1996-03-20 Pfizer Ltd Parasiticidal compounds
CN1531426A (en) * 2000-12-20 2004-09-22 ��˹��ŵ�� Organic compounds
TWI261053B (en) * 2001-12-06 2006-09-01 Novartis Ag Amidoacetonitrile compounds, their preparation, compositions and use as pesticides
ES2250921T3 (en) 2002-08-12 2006-04-16 Bayer Cropscience S.A. NEW DERIVATIVE OF 2-PIRIDILETILBENZAMIDA.
EP1960350B1 (en) * 2005-11-22 2015-08-19 Bayer Intellectual Property GmbH New n-(1-methyl-2phenylethyl)benzamide derivatives
TWI435863B (en) * 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd N-2-(hetero) arylethylcarboxamide derivative and pest controlling
JP2009542601A (en) 2006-07-06 2009-12-03 バイエル・クロツプサイエンス・エス・アー N- (4-pyridin-2-ylbutyl) benzamide derivatives and their use as fungicides
WO2008003746A1 (en) 2006-07-06 2008-01-10 Bayer Cropscience Sa N-(4-pyridin-2-ylbutyl) carboxamide derivatives, their process of preparation and their use as fungicides
CL2008000512A1 (en) 2007-02-22 2008-08-29 Bayer Cropscience Sa COMPOUNDS DERIVED FROM N- (3-PHENYLPROPIL) CARBOXAMIDE; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; FUNGICIDE COMPOSITION; AND METHOD FOR FIGHTING PREVENTIVE OR CURATIVE FITOPATOGEN MUSHROOMS.
JP2010519276A (en) 2007-02-22 2010-06-03 バイエル・クロツプサイエンス・エス・アー Novel N- (3-phenylpropyl) benzamide derivatives
HUE029331T2 (en) 2007-04-12 2017-02-28 Nihon Nohyaku Co Ltd Nematicidal agent composition and method of using the same
WO2009012998A1 (en) 2007-07-26 2009-01-29 Syngenta Participations Ag Novel microbiocides
GB0807140D0 (en) 2008-04-18 2008-05-21 Syngenta Participations Ag Novel microbiocides
GB0904658D0 (en) 2009-03-18 2009-04-29 Syngenta Crop Protection Ag Novel microbiocides
ES2527833T3 (en) * 2009-03-25 2015-01-30 Bayer Cropscience Ag Combinations of nematicidal active ingredients comprising fluopiram and other active substance
EP2782572A1 (en) * 2011-11-25 2014-10-01 Bayer Intellectual Property GmbH Use of fluopyram for controlling endoparasites

Also Published As

Publication number Publication date
CN103415288B (en) 2018-04-03
NZ613343A (en) 2015-09-25
ZA201305979B (en) 2014-10-29
AU2012224015A1 (en) 2013-09-26
JPWO2012118139A1 (en) 2014-07-07
AU2012224015B2 (en) 2017-04-13
CN108524480A (en) 2018-09-14
BR112013021337B1 (en) 2019-09-03
BR112013021337A2 (en) 2016-11-01
CL2013002507A1 (en) 2014-05-23
JP5973989B2 (en) 2016-08-23
WO2012118139A1 (en) 2012-09-07
RU2013144215A (en) 2015-04-10
MX2013009957A (en) 2013-12-06
CN103415288A (en) 2013-11-27
ES2625990T3 (en) 2017-07-21
RU2596788C2 (en) 2016-09-10
UA114287C2 (en) 2017-05-25
EP2682115B1 (en) 2017-04-19
US9447042B2 (en) 2016-09-20
EP2682115A4 (en) 2014-11-26
KR20140011341A (en) 2014-01-28
US20140088157A1 (en) 2014-03-27
CA2828060C (en) 2018-11-06
CA2828060A1 (en) 2012-09-07
MX345339B (en) 2017-01-25
KR101856577B1 (en) 2018-05-10
EP2682115A1 (en) 2014-01-08

Similar Documents

Publication Publication Date Title
PH12013501809A1 (en) Endoparasite control agent
AU2013291345B2 (en) Composition for controlling plant disease and application therefor
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
BR112012026767A2 (en) compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, method for treating or preventing disorders, and use of a compound or salt
MX2013012542A (en) Amide compound and pharmaceutical application therefor.
PH12015501363B1 (en) Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
MX2013011589A (en) Methods and compositions for treating parkinson's disease.
TN2013000413A1 (en) Glycoside derivatives and their uses for the treatment of diabetes
TN2012000092A1 (en) Therapeutic agent for mood disorders
MX2015003594A (en) Therapeutic or prophylactic agent for tumor lysis syndrome.
WO2012118308A3 (en) Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
PH12016502246A1 (en) Carboxamide derivatives
WO2012140596A8 (en) Glycoside derivatives and uses thereof
PH12015501146A1 (en) Hydantoin derivative
TN2014000060A1 (en) Benzothiazolone compound
TN2012000093A1 (en) Therapeutic agent for anxiety disorders
MX2013008269A (en) Pharmaceutical composition comprising pyridone derivatives.
WO2012118309A3 (en) Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same
WO2013062332A3 (en) Vascular anti-aging composition including syringaresinol
PH12019501027A1 (en) Therapeutic drug or prophylactic drug for diabetic nephropathy
TN2015000058A1 (en) Salts of benzothiazolone compound as beta-2-adrenoceptor agonist
WO2012128530A3 (en) 2-methyl-2-alkyl-6-amido-2h-benzopyran derivatives having anti-cancer activity
WO2012169863A3 (en) 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
PH12011000381A1 (en) Pesticidal composition and method for controlling pests
WO2013035997A3 (en) Pharmaceutical composition for preventing or treating alopecia comprising tianeptine or its salt